Traditional patient recruitment in clinical research often reduces patients to age, gender, or diagnosis, missing the deeper identities like caregiver, fighter, skeptic, or advocate that shape how people view research. Their identities shape how they see medical research and how they decide whether to participate. When clinical teams acknowledge this complexity, we open the door to stronger relationships and more meaningful outcomes.
When our outreach centres only on demographics we risk missing the deeper motivations that drive participation. For example, a patient may be eligible for a study based on their diagnosis, but if they see themselves primarily as a caregiver to children, their main concern will be how participation fits into family life. Speaking to identity means understanding these contexts and tailoring support accordingly. This shift is critical for patient recruitment in clinical research. It acknowledges that decisions are shaped by personal stories as much as medical eligibility.
Patients bring their whole selves to the process. We must not see them as just trial participants, but as real people balancing hope, fear, responsibility, and identity. Recognising and respecting these identities helps build trust, as patients feel seen as people rather than data points. It also creates space for dialogue rather than one-sided instruction. When our outreach reflects who patients are, not just what category they fit into, participation becomes an act of collaboration rather than compliance.
Understanding Lived Experience
Every patient carries a lived experience that extends beyond the clinical record. Some approach trials as fighters who want to take an active role in exploring treatment options. Others are sceptical, wary of risk or previous negative experiences with healthcare. Still others may be navigating cultural expectations or personal identities that influence how they interpret trial information.
By recognising these identities, we can tailor our approach. For the fighter, communication can highlight empowerment and contribution to progress. For the sceptic, transparency and reassurance may be central. For the caregiver, offering logistical support like flexible scheduling or transport may help reduce barriers. None of these approaches can be derived from demographics alone. They require listening and responding to the stories patients share with us.
This respect for lived experience demonstrates that we value patients beyond the data they provide. It affirms that their journey is understood. This acknowledgement can transform the perception of trials from transactional to relational. It helps patients feel that their presence matters not just for research outcomes, but for who they are as people.
Building Trust Through Identity Alignment
Trust does not appear instantly in clinical trials. It is built gradually, often in the earliest conversations. Patients weigh whether we recognise their concerns and values. When their identity is acknowledged, patients sense authenticity. They feel less like numbers and more like partners.
Outreach strategies that align with identity (for example, framing a trial as an opportunity to “help others” for caregivers, or as “access to new options” for fighters) resonate more authentically. Trust grows when patients see their identity reflected in the way information is shared and decisions are respected.
In practice, this means we listen carefully during consent conversations and follow-ups. It means we train teams to recognise cues about identity and adapt responses. It means we create materials that speak to varied experiences rather than offering a single, one-size-fits-all narrative. These practices strengthen the bond with our patient, laying a foundation for sustained engagement.
The Role of Personalised Clinical Engagement
As trials expand globally, the diversity of identities becomes even more pronounced. Cultural values, family roles, and community ties influence decisions in ways that numbers alone cannot capture. This is why personalised clinical engagement is essential. By creating tailored strategies, we can connect with patients on terms that reflect their realities.
Personalisation does not require complex systems. It begins with empathy and awareness. A trial coordinator who takes the time to ask about family responsibilities or cultural needs signals respect. Offering communication in plain language, translated materials, or flexible touchpoints also shows responsiveness. These efforts tell patients that their identities are central, not peripheral.
Personalised clinical engagement also helps strengthen inclusivity. Trials that recognise varied identities are more likely to attract diverse patients. This diversity not only improves the scientific value of trials, but also makes patients feel their communities are seen and represented. It creates a sense of belonging rather than distance.
Moving Beyond Demographics for Patient Recruitment in Clinical Research
Demographic details will always play a role in clinical trial design, but they should not be our only guide for outreach. Identity-driven communication ensures that patients feel understood as individuals. It acknowledges the fears of sceptics, the dedication of caregivers, and the hope of fighters. It embraces the fact that participation is never just about medical data. It is about personal values, responsibilities, and aspirations.
Personalised engagement fosters stronger participation and retention, as patients feel that their values and lived realities are respected. It also encourages feedback that can refine future trial designs to be more patient-centred. Over time, this builds a culture of collaboration where patients are not simply participants, but true partners.
This cultural shift requires commitment, but the rewards are clear. Trials become more inclusive. Patients feel valued. Outcomes improve. And the relationship between research and community grows stronger. Respect for patient identity turns clinical research into a shared journey rather than a solitary one.
Expanding this approach requires continuous dialogue with patients throughout the trial, not only at entry. Patients’ identities can shift as they progress through treatment or encounter new life challenges. A caregiver may later see themselves as an advocate. A sceptic may become a supporter after positive experiences. Recognising that identity is dynamic allows us to adjust engagement over time. Ongoing surveys, advisory boards, and open feedback sessions help capture these changes. This adaptability ensures patients remain connected not just as participants, but as people whose evolving stories are respected.
By speaking to identity as well as demographics, clinical research can move closer to true partnership with patients. Let’s speak about designing outreach that honours identity and builds trust across every stage of research.
Keith Berelowitz | Founder & CEO
Keith Berelowitz is the Founder of pRxEngage, a company redefining patient engagement and retention in clinical trials using living experience, proven methods, and AI.
